top of page
Browse by category
Search
FDA approves labelling update for VIVUS’ QSYMIA
The FDA has approved a labelling update for VIVUS’ QSYMIA (phentermine and topiramate extended-release capsules CIV) that has removed the...
Phenomix Sciences and InformedDNA enter partnership to advance genetics-driven obesity care
Phenomix Sciences has formed a new partnership to advance precision medicine in obesity with InformedDNA, that integrates Phenomix’s...
First patient enrolled in Endogenex’ ReCET clinical study
Endogenex has enrolled the first patient in the Re-Cellularization via Electroporation Therapy ( ReCET) clinical study, multi-centre,...
Implantica prepares Module 2 submission of PMA application to FDA for RefluxStop
Implantica has announces finalisation of the five-year CE mark study results as part of the upcoming Module 2 submission (of 3 modules)...
FDA grants De Novo marketing authorisation to GT Metabolic Solutions for its magnet compression anastomosis technology
GT Metabolic Solutions has announced its first-generation MagDI System for side-to-side duodeno-ileal anastomosis has been granted De...
Ten years in endobariatrics – the past, present and future
Bariatric News talked to Letizia Ceccarelli, Head of International Marketing – Endobariatrics at Boston Scientific about the changes she...
Olympus launches new Powerseal Sealer/Divider 5mm devices extending advanced bipolar surgical energy portfolio
Olympus has launched two new jaw designs in the Powerseal Sealer/Divider range of advanced bipolar surgical energy products: the...
Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity
Eli Lilly and Company has announced Zepbound (tirzepatide) 2.5mg and 5mg single-dose vials are available for self-pay for patients with...
FDA expands Ethicon’s Linx Reflux Management System to include patients with Barrett’s esophagus experiencing GERD
The FDA has approved a label update to expand the availability of Ethicon’s Linx Reflux Management System to include patients with...
ANSM suspends Allurion gastric balloons in France
The Agence nationale de sécurité du médicament et des produits de santé (ANSM, National Medicines Safety Agency) in France has suspended...
Browse by tag
bottom of page